USPTO serial 99152088
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew M. Smith
Andrew M. Smith Resonate IP, LLCP.O. Box 1650Bend, OR 97709United States| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Pharmaceutical drug research and development services; Good Manufacturing Practices (GMPs) laboratory product testing and chemical analysis services; testing and analysis services, namely, product testing and chemical analysis of manufactured materials and pharmaceutical products; testing and analysis services, namely, product quality testing and evaluation of raw materials, compounded preparations, pharmaceutical excipients, and pharmaceutical drug products; development, validation, and execution of analytical and physical testing methods for raw materials, compounded preparations, pharmaceutical excipients, and pharmaceutical drug products; testing, analysis, and evaluation of the goods of others to assure compliance with industry standards in the nature of Good Manufacturing Practices (GMPs); analytical scientific laboratory services and chemical scientific laboratory services with formulation support; quality control services for others, namely, quality audits, product testing, and product quality system testing for raw materials, compounded preparations, pharmaceutical excipients, and pharmaceutical drug products; technology supervision and consulting services in the field of product quality control to assure compliance with biopharmaceutical laws and regulations; preparing biopharmaceutical compliance reports and validation protocols for biopharmaceutical facilities, equipment, and processes for the purpose of assuring compliance with industry standards; consulting services to biopharmaceutical companies in the field of testing, analysis, and evaluation of manufacturing equipment and manufacturing processes to assure compliance with Good Manufacturing Practice (GMP) industry standards | ACTIVE | Jul 14, 2026 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 22, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 3, 2026 | IUAF | USE AMENDMENT FILED | — |
| Sep 3, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 7, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 12, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 12, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 6, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 16, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 25, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 25, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 25, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 9, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 9, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 9, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 4, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 4, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 4, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 23, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 23, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 23, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 23, 2025 | NWAP | NEW APPLICATION ENTERED | — |